首页> 外文期刊>Human Pathology >Biological and clinical significance of NAC1 expression in cervical carcinomas: A comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas
【24h】

Biological and clinical significance of NAC1 expression in cervical carcinomas: A comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas

机译:NAC1表达在宫颈癌中的生物学和临床意义:鳞状细胞癌和腺癌/腺鳞癌之间的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

This study examined the biological and clinical significance of NAC1 (nucleus accumbens associated 1) expression in both cervical squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas. Using immunohistochemistry, the frequency of positive NAC1 expression in adenocarcinomas/adenosquamous carcinomas (31.0%; 18/58) was significantly higher than that in squamous cell carcinomas (16.2%; 12/74) (P =.043). NAC1 gene amplification was identified by fluorescence in situ hybridization in 5 (7.2%) of 69 squamous cell carcinomas. NAC1 amplification was not identified in the adenocarcinomas (0%; 0/58). Positive NAC1 expression was significantly correlated with shorter overall survival in squamous cell carcinomas (P <.0001). A multivariate analysis showed that positive NAC1 expression in squamous cell carcinomas was an independent prognostic factor for overall survival after standard radiotherapy (P =.0003). In contrast to squamous cell carcinomas, positive NAC1 expression did not correlate with shorter overall survival in adenocarcinomas/adenosquamous carcinomas (P =.317). Profound growth inhibition, increased apoptosis, decreased cell proliferation, and decreased cell migration and invasion were observed in silencing RNA-treated cancer cells with NAC1 overexpression compared with cancer cells without NAC1 expression. NAC1 overexpression stimulated proliferation, migration, and invasion in the cervical cancer cell lines TCS and Hela P3, which normally lack NAC1 expression. These findings indicate that NAC1 overexpression is critical to the growth and survival of cervical carcinomas irrespective of histologic type. Furthermore, they suggest that NAC1 silencing RNA-induced phenotypes depend on the expression status of the targeted cell line. Therefore, cervical carcinoma patients with NAC1 expression may benefit from a targeted therapy irrespective of histologic type.
机译:这项研究检查了NAC1(伏伏核相关1)在宫颈鳞状细胞癌和腺癌/腺鳞癌中的生物学和临床意义。使用免疫组织化学,NAC1阳性表达在腺癌/腺鳞癌中的发生频率(31.0%; 18/58)显着高于鳞状细胞癌(16.2%; 12/74)(P = .043)。 NAC1基因扩增通过荧光原位杂交在69例鳞状细胞癌中的5例(7.2%)中得以鉴定。在腺癌中未鉴定到NAC1扩增(0%; 0/58)。 NAC1阳性表达与鳞状细胞癌的总体生存期较短有显着相关性(P <.0001)。多元分析表明,鳞状细胞癌中NAC1阳性表达是标准放疗后总体生存的独立预后因素(P = .0003)。与鳞状细胞癌相比,NAC1阳性表达与腺癌/腺鳞癌的总体生存期较短无关(P = .317)。与没有NAC1表达的癌细胞相比,在沉默处理过的具有NAC1过表达的RNA处理的癌细胞中观察到了深刻的生长抑制,凋亡增加,细胞增殖减少以及细胞迁移和侵袭减少。 NAC1的过表达刺激了通常缺乏NAC1表达的宫颈癌细胞株TCS和Hela P3的增殖,迁移和侵袭。这些发现表明,无论组织学类型如何,NAC1的过表达对于宫颈癌的生长和存活至关重要。此外,他们暗示NAC1沉默RNA诱导的表型取决于目标细胞系的表达状态。因此,无论组织学类型如何,具有NAC1表达的宫颈癌患者均可受益于靶向治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号